Mechanistic considerations in risk assessment for epigenetic tumor-promoting carcinogens.
Division of Pathology and Toxicology, American Health Foundation, Valhalla, NY 10595, USA.
G M
GM
Williams
J
J
Whysner
D000818:Animals; D002083:Butylated Hydroxyanisole / Q000633:toxicity; D002273:Carcinogens / Q000633:toxicity*; D053138:Cyclohexenes; D004305:Dose-Response Relationship, Drug; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects*; D006801:Humans; D000077222:Limonene; D010634:Phenobarbital / Q000633:toxicity; D018570:Risk Assessment; D013045:Species Specificity; D013729:Terpenes / Q000633:toxicity
D002273:Carcinogens; D053138:Cyclohexenes; D013729:Terpenes; D002083:Butylated Hydroxyanisole; D000077222:Limonene; D010634:Phenobarbital